COVID-19
От обычной простуды к пневмонии: роль макрофагов при коронавирусе
Активированные интерстициальные макрофаги как мишень для лечения COVID-19
Аутоантитела к интерферонам не связаны с хронической усталостью после COVID-19
Только у 1,6% пациентов с постковидным синдромом есть аутоантитела к ИФН-β
Autoantibodies to Type I Interferons in COVID-19 Patients
A Systematic Review and Meta-Analysis
Genetic Trick of Omicron: Evasion of the Innate Immune System
Coronavirus gene Orf6 suppresses immune responses
Macrophages Shield Against Excessive Inflammation in Respiratory Viral Infections
Macrophages produce oncostatin M and suppress the excessive interferon response
Why Does Coronavirus Make You Sneeze
The coronavirus protein enhances pain sensitivity
How the Complement System Contributes to Post-COVID Syndrome
Tissue Damage and Herpes Virus Reactivation Increase Complement Activity
COVID-19 and Autoimmune Neurological Disorders: Vaccination Safety
How coronavirus vaccination affects patients with multiple sclerosis, myasthenia gravis and neuromyelitis optica
Quercetin – an Antioxidant with Neuroprotective and Antiviral Properties
Overview of the Therapeutic Effects of Quercetin
Cardiovascular Risks in COVID-19 vs. Other Pulmonary Infections: A Comparative Analysis
Patients with COVID-19 often exhibit myocardial damage, associated with adverse outcomes and high mortality rates
Antibody-Free Protection: The Effectiveness of COVID-19 Vaccination in Patients with B-Cell Deficiency
Enhanced T-cell responses with B-cell deficiency reduce the risk of severe COVID-19 by 5-fold
Confronting the Invisible Enemy: How Viral Reservoirs Impact Health Post COVID-19
Mechanisms through which coronavirus can remain in the body and their role in post-COVID syndrome
Post-COVID Syndrome Linked to Low Serotonin Levels
Viral inflammation disrupting serotonin synthesis and accumulation
A Pan-Coronavirus Nasal Vaccine Developed in Hong Kong
A nasal vaccine containing interferon protects Omicron and other coronavirus strains
Protection Against Omicron: New Vaccines on the Horizon
The World Health Organization has recommended a monovalent vaccine based on the Kraken strain, a subvariant of Omicron
COVID-19 Increases the Risk of Osteoporosis
Inflammatory Cytokines Trigger Bone Tissue Degradation
Interferon Alpha-2b Enhances Protection Against Omicron in Vaccinated Individuals
A Study on High-Risk Medical Workers
Coronavirus Pyrola: Do Vaccines and Previous Infection Protect Against Other Strains?
Mutations in the Spike Protein Help Pyrola Evade Immune Protection
Post-COVID Syndrome and Multi-Organ Failure
Three Out of Five People with Post-COVID Syndrome Experience Organ Dysfunction
Properties and Antiviral Activity of Interferon Epsilon
IFN-ε may protect against HIV
Modified Interferon α2 Inhibits Coronavirus Replication and Inflammation
IFNmod protects against IFN-I-associated lung injury
Metformin Reduces COVID-19 Severity in Prediabetic Patients
For patients with PCOS, results are similar
Asymptomatic Coronavirus Gene Found
Mutation of the HLA system gene helps trigger antiviral response faster
Indigenous Peoples in Australia More Severely Ill COVID-19
The reason for the weak antibody response is chronic diseases
Efficacy and Safety of Type I and III Interferons in the Treatment of COVID-19
Systematic review and meta-analysis
Prevention of COVID-19 in Pregnant Women
Evaluation of the effectiveness of intranasal and rectal interferon-alpha, vaccination and umifenovir
The Introduction of Intranasal Interferon-Alpha During COVID-19 Vaccination Increases the Effectiveness and Longevity of Vaccines
IFN-alpha forms sterilizing immunity of the mucous membranes of the upper respiratory tract
How Paracetamol Acts in Flu
NSAIDs change neuronal response to influenza, reducing mortality
Type I Interferon Protects against Hyperinflammation and Tissue Damage
Interferon inhibits the production of enzymes by macrophages that destroy tissue structure
Post-Covid-19 Cognitive Impairment Associated with Antiviral Type I Interferon Response in the Choroid Plexus
Restoring systemic immunity and regular IFN-gamma activity may prevent cognitive impairment
Early COVID-19 Treatment with Pegylated Interferon-Lambda
Single subcutaneous injection of IFN-lambda prevents hospitalization and reduces mortality
COVID-19 Complication: Facial Nerve Palsy Associated with Fungal Infection
Immunosuppression in COVID-19 contributes to the development of mucormycosis
Simultaneous COVID-19 and Flu: How Coinfection Affects The Outcome of The Disease
Impact of influenza on coronavirus infection
Influenza Virus Interferes with Coronavirus’ Ability to Infect Lungs and Heart
The role of interferon and nitric oxide in the suppression of coronavirus replication
Fungal Infections with Coronavirus
Candida fungus linked to COVID-19 deaths
Cause of Mental Disorders in COVID-19
Inflammatory proteins disrupt hippocampal neurogenesis
Ways to Overcome Chronic Fatigue after COVID-19
Post-Covid Syndrome Treatment: Vagus Nerve Stimulation
Interferon-α2b Spray Shortens The Infectious Period of Omicron
Only administration up to 3 days from the onset of the disease is effective
How Much Virus Does A Person With COVID-19 Breathe Out
Patients with Omicron can shed 1,000 times more viral RNA than with Alpha and Delta strains
Omicron and Delta are The Most Interferon-Resistant COVID-19 Strains
IFN-alpha8, IFN-beta, and IFN-omega coronavirus are most effectively suppressed
IgM Antibodies Protect Against Delta and Omicron Strains
IgM antibodies derived from memory B cells neutralize a wide range of coronavirus strains
Nasal Interferon is Only Effective if Administered before COVID-19 Symptoms Appear
Interferon-alpha is effective the day before or one day after infection with SARS-CoV-2
Omicron is Resistant to Interferon Response
However, exogenous interferon inhibits Omicron
Nasal Vaccines Against COVID-19
Nasal vaccines, in addition to intramuscular ones, stimulate mucosal immunity
Interferon to Prevent and Treat Respiratory Viral Infections
Review of human studies
COVID-19 and Down Syndrome
Increased activity of the interferon system complicates the course of COVID-19
The Post-COVID Syndrome: Symptoms, Causes, Treatment
Chronic inflammation of the heart and acute kidney injury after COVID-19
Cognitive Impairment After COVID-19: Brain Fog And Memory Problems
Is Cognitive Recovery Possible After COVID-19?
GMOP-IFN-Alpha-2b: Stable De-Immunized Interferon
Non-immunogenic interferon with a long elimination period can help in the treatment of chronic hepatitis and other viral diseases
Pegylated Interferon-Lambda Protects Against Severe COVID-19
A single subcutaneous injection of interferon-lambda twice reduces the risk of hospitalizations with COVID-19
Inflammatory Cytokines Cause Cardiac Arrhythmias in COVID-19
Cytokines IL-6 and IL-10 are risk factors for atrial and ventricular arrhythmias
ACE2 Decoy Prevents Omicron Infection
Engineered ACE2 prevents the coronavirus from binding to the cell
Diet in COVID-19: Five Facts About Antiviral Nutrition
How dietary habits, vitamins, and trace elements affect immunity
Genetic Disorders Cause Smell Loss In COVID-19
COVID-19 impairs sensory neuron function by suppressing olfactory receptor genes
Intranasal Interferon-Λ Protects Against Omicron Strain
Type III interferon suppresses coronavirus infection of the upper and lower respiratory tract
Zinc Deficiency Affects Taste Changing After COVID-19
Prescripted Zinc Supplements Accelerate Taste Recovery After COVID-19
Why Omicron is A Milder But More Contagious Disease
Omicron multiplies rapidly in the bronchi but affects the lungs less
Post-Vaccination and Natural COVID-19 Antibodies: Which Protect Better?
S-protein in a closed state as the basis of future vaccines
Physical Activity after COVID-19 and Flu Vaccination Increases The Level of Antibodies
Physical activity stimulates the production of interferon-alpha and increases the effectiveness of vaccines
Interferon-Alpha-2b Inhalations Improve Clinical Outcome in COVID-19
Early treatment with interferon-alpha-2b reduces the risk of severe COVID-19 outcomes by 64%
Interferon-Alpha in COVID-19: A Systematic Review
Interferon-alpha in combination with antivirals accelerates recovery from COVID-19
Omicron: Disease Duration
Quarantine terms for infection with Omicron
Omicron Triggers Interferon Response Leading to Mild COVID-19
How Omicron mutations affect the treatment and course of the disease
Do Vaccines Protect Against Omicron Strain?
Individuals vaccinated with Sputnik V retain a neutralizing response against the Omicron strain
Interferon, Statins, Janus Kinase Inhibitors and Hydroxyurea to Treat COVID-19
What factors influence severe COVID-19?
Combined Interferon And Janus Kinase 1/2 Inhibitor In Treating COVID-19
Ruxolitinib and interferon resist cytokine storm and thrombosis; interferon inhibits viral replication
Vaccination Against COVID-19: Heart Complications Risks
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination and SARS-CoV-2 infection
Common Cold Immunity Protects Children From COVID-19
Protein S2 – a promising basis for future coronavirus vaccines
Severe COVID-19 causes chronic kidney failure
SARS-CoV-2 infects the kidneys and is associated with subsequent fibrosis
Do Autoimmune Diseases Predispose to Severe COVID-19
And can SARS-CoV-2 infection cause autoimmunity?
Senolytics Prevent Severe Coronavirus
Virus-induced cell senescence is a driving force and therapeutic target for COVID-19
Genetically Engineered IFN vs Conventional IFN Against COVID-19
New genetically engineered interferon-alpha accelerates clinical improvement in coronavirus
Interferon and Glucocorticoids Early Injection Accelerates Recovery From COVID-19
Interferon restores antiviral immunity suppressed by glucocorticoids
Interferon-Gamma Treats Long-Term Coronavirus
Interferon-γ stimulation helps with prolonged COVID-19 in immunosuppressed patients
Omega-3 fatty acids protect against COVID-19
Consumption of fatty fish and supplements of EPA and DHA to reduce inflammation and the risk of cytokine storm during the coronavirus
Early Interferon Response Protects Children From Severe COVID-19
In children, innate immunity is pre-activated, so children suppress SARS-CoV-2 faster
How Long Do Antibodies Persist After COVID-19
After natural SARS-CoV-2, protection against reinfection persists for about two years
Late Treatment of COVID-19 Patients with Interferon-Beta Increases Mortality
A double-blind, randomized, placebo-controlled study
What Level of Neutralizing Antibodies Protects Against COVID-19
Antibody titers predict the protective efficacy of vaccines
COVID-19 Symptoms Depend on The Infecting Dose
SARS-CoV-2 dose affects seroconversion and fever
Combined Nafamostat and Interferon-Alpha Suppresses The SARS-Cov-2
The drugs have a synergistic effect in vitro and in vivo due to the joint impact on TMPRSS2
Will COVID-19 Vaccination Affect Future Pregnancy?
No, the coronavirus vaccine does not cause infertility and does not increase the risk of miscarriage
Interferon for The Intestinal Form of Coronavirus
Type III interferon suppresses SARS-CoV-2 in intestinal epithelial cells more effectively than type I interferon
Vape, Cigarettes and Hookah Provoke Coronavirus Infection Even in Teenagers and Youngers
Tobacco smoke and vaping vapor suppress innate immunity and contribute to severe COVID-19. Passive smokers are also at risk
Is It Possible to Get Coronavirus and Flu at The Same Time
Coinfection with SARS-CoV-2 and influenza causes life-threatening illness
Anticoagulants Reduce Risk of Severe COVID-19
Blood thinners reduce hospital admissions and mortality for coronavirus disease
Multiple Sclerosis Coronavirus Vaccination
When antibodies are low, a protective T-cell response is maintained
Interferon Prevents Coronavirus Cytokine Storm in Diabetic Patients
Interferon increases levels of the enzyme SETDB2, which suppresses inflammation
Reinfection with COVID-19 is Possible Even with A High Titer of Neutralizing Antibodies
World statistics and studies of re-cases of coronavirus infection
Do COVID-19 vaccines provide protective immunity? World experience: statistics and research
People vaccinated against coronavirus can get asymptomatic and contagious, while those vaccinated with symptoms get sick easier and faster
T Cell Response to Vaccination Protects Against New Strains of Coronavirus
T cells from people who have recovered from COVID-19 or received vaccines can recognize different strains of SARS-CoV-2
Interferon Autoantibodies Increase The Risk of Critical COVID-19 in Elders
Autoantibodies that neutralize type I interferons are present in 4% of uninfected people over 70 and are responsible for 20% of deaths from COVID-19
COPD Changes Susceptibility to SARS-CoV-2 Coronavirus
Inhaled corticosteroids reduce ACE2 receptor expression in COPD by inhibiting type I interferon
Intranasal Form of Interferon-Alfa-2b for The Prevention and Treatment Of COVID-19
Small doses of interferon are required to obtain a beneficial effect
Vaccination against COVID-19 for immunocompromised people
Three doses of coronavirus vaccine instead of the usual two
Vaccination in Pregnancy: Newborn Receives Protective Maternal Antibodies to Coronavirus
Antibodies to SARS-CoV-2 are more efficiently transmitted by vaccination than by natural infection